<DOC>
	<DOCNO>NCT02134249</DOCNO>
	<brief_summary>The purpose study compare effect oral Diosmin oral Cabergoline prevention ovarian hyperstimulation syndrome ( OHSS ) high-risk woman underwent intracytoplasmic sperm injection ( ICSI ) .</brief_summary>
	<brief_title>Diosmin Versus Cabergoline Prevention Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description>Two hundred woman risk ovarian hyperstimulation syndrome ICSI cycle randomly schedule two equal group . In group A , ( Diosmin group ) , 2 tab / 8 h Diosmin ( 500mg ) give day HCG injection 2 week ; group B ( Cabergoline group ) , 1 tab/day Cabergoline ( 0.5 mg ) give day HCG injection eight day .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<criteria>infertile woman undergo intracytoplasmic sperm injection polycystic ovarin syndrome ( PCO ) one following : 1 . Presence 20 follicle ultrasound 2 . E2 3000 pg/ml 3 . Retrieval 15 follicle</criteria>
	<gender>Female</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>infertility</keyword>
	<keyword>ICSI</keyword>
	<keyword>OHSS</keyword>
	<keyword>Diosmin</keyword>
	<keyword>Cabergoline</keyword>
</DOC>